These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38163369)

  • 1. In medical inpatients, the IMPROVE risk score had moderate predictive power for 14-d in-hospital bleeding.
    Tafur AJ; Douketis JD
    Ann Intern Med; 2024 Jan; 177(1):JC11. PubMed ID: 38163369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of in-hospital bleeding in acutely ill medical patients: External validation of the IMPROVE bleeding risk score.
    Villiger R; Julliard P; Darbellay Farhoumand P; Choffat D; Tritschler T; Stalder O; Rossel JB; Aujesky D; Méan M; Baumgartner C
    Thromb Res; 2023 Oct; 230():37-44. PubMed ID: 37634309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In acutely ill inpatients, benefits and harms of anticoagulants for VTE prophylaxis were assessed.
    Shivakumar S
    Ann Intern Med; 2022 Nov; 175(11):JC128. PubMed ID: 36315952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score.
    Hostler DC; Marx ES; Moores LK; Petteys SK; Hostler JM; Mitchell JD; Holley PR; Collen JF; Foster BE; Holley AB
    Chest; 2016 Feb; 149(2):372-9. PubMed ID: 26867833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.
    Decousus H; Tapson VF; Bergmann JF; Chong BH; Froehlich JB; Kakkar AK; Merli GJ; Monreal M; Nakamura M; Pavanello R; Pini M; Piovella F; Spencer FA; Spyropoulos AC; Turpie AG; Zotz RB; Fitzgerald G; Anderson FA;
    Chest; 2011 Jan; 139(1):69-79. PubMed ID: 20453069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of the prognostic value of the CRUSADE score in patients with acute coronary syndromes hospitalized in a noninvasive hospital].
    Kharchenko MS; Erlikh AD; Gratsianskiĭ NA
    Kardiologiia; 2012; 52(8):27-32. PubMed ID: 23098395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary risk model for inhospital major bleeding for patients with acute myocardial infarction: The acute coronary treatment and intervention outcomes network (ACTION) registry®-Get With The Guidelines (GWTG)®.
    Desai NR; Kennedy KF; Cohen DJ; Connolly T; Diercks DB; Moscucci M; Ramee S; Spertus J; Wang TY; McNamara RL
    Am Heart J; 2017 Dec; 194():16-24. PubMed ID: 29223432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we IMPROVE bleeding risk assessment for acutely ill, hospitalized medical patients?
    Tay KH; Lip GY; Lane DA
    Chest; 2011 Jan; 139(1):10-3. PubMed ID: 21208874
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany.
    Schädlich PK; Kentsch M; Weber M; Kämmerer W; Brecht JG; Nadipelli V; Huppertz E
    Pharmacoeconomics; 2006; 24(6):571-91. PubMed ID: 16761905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients.
    Spyropoulos AC
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):506-514. PubMed ID: 36485109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.
    Stuck AK; Spirk D; Schaudt J; Kucher N
    Thromb Haemost; 2017 Apr; 117(4):801-808. PubMed ID: 28150851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
    Hong MT; Monye LC; Seifert CF
    Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™.
    Mathews R; Peterson ED; Chen AY; Wang TY; Chin CT; Fonarow GC; Cannon CP; Rumsfeld JS; Roe MT; Alexander KP
    Am J Cardiol; 2011 Apr; 107(8):1136-43. PubMed ID: 21324428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary adequacy of thromboprophylaxis in acutely ill medical patients in Switzerland: a bi-centric prospective cohort.
    Marando M; Blondon K; Darbellay Farhoumand P; Nendaz M; Grauser D; Sallet A; Tamburello A; Pons M; Righini M; Gianella P; Blondon M
    Swiss Med Wkly; 2023 Nov; 153():40117. PubMed ID: 37956238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, causes, medical interventions, and mortality outcome of acute gastrointestinal bleeding among COVID-19 inpatients.
    Luu MN; Dang TP; Vo MH; Quach DT
    Curr Med Res Opin; 2023 May; 39(5):731-737. PubMed ID: 37026739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient selection for thromboprophylaxis in medical inpatients.
    Bozzato S; Squizzato A; Donadini MP; Guasti L; Dentali F; Ageno W
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1639-47. PubMed ID: 24215194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of HAS-BLED and CRUSADE risk scores for the prediction of haemorrhagic events in patients with stable coronary artery disease.
    Yildirim E; Uku O; Bilen MN; Secen O
    Cardiovasc J Afr; 2019 Jul/Aug 23; 30(4):198-202. PubMed ID: 31141005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project.
    Guo YT; Zhang Y; Shi XM; Shan ZL; Wang CJ; Wang YT; Chen YD; Lip GY
    Sci Rep; 2016 Aug; 6():31755. PubMed ID: 27557876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of bleeding after cardiac surgery: comparison of model performances: a prospective observational study.
    Greiff G; Pleym H; Stenseth R; Berg KS; Wahba A; Videm V
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):311-9. PubMed ID: 25529438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.
    Goldin M; Lin SK; Kohn N; Qiu M; Cohen SL; Barish MA; Gianos E; Diaz A; Richardson S; Giannis D; Chatterjee S; Coppa K; Hirsch JS; Ngu S; Firoozan S; McGinn T; Spyropoulos AC
    J Thromb Thrombolysis; 2021 Nov; 52(4):1032-1035. PubMed ID: 34146235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.